TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SERA

Sera Prognostics Inc

Healthcare · Medical Devices

2.10$ +0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement SERA
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
50.0% 44.0% 45.1% 72.0% 68.6% 106.5% 202.5%
50.0% 56.0% 54.9% 28.0% 31.4% -6.5% -102.5%
25,980.6% 31,128.0% 13,437.8% 5,314.9% 4,975.5% 19,129.9% 16,260.5%
11,883.3% 26,232.0% 17,186.6% 6,262.7% 5,340.8% 20,946.8% 20,619.8%
46,094.4% 71,940.0% 43,219.5% 17,062.3% 13,044.8% 47,571.4% 44,964.2%
-46,044.4% -71,884.0% -43,164.6% -17,034.3% -13,013.4% -47,577.9% -45,066.7%
5,477.8% 7,356.0% 909.8% 22.8% 18.0% 36.4% 11.1%
-45,891.7% -79,392.0% -42,693.9% -16,487.3% -11,843.8% -42,724.7% -39,417.3%
10,883.3% 7,036.0% 1,486.6% 22.8% 239.3%
-45,891.7% -79,392.0% -42,693.9% -16,487.3% -11,843.8% -42,724.7% -39,417.3%
-37,786.1% -68,456.0% -40,980.5% -16,182.5% -11,531.7% -41,606.5% -38,245.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?